BACKGROUD: Panama Canal Area Benefit Plan (PCABP) is a Benefit Plan administered by AXA Assistance.Axa-Assistance represents around 35-40% of private health market in Panama. Our Plan has more than 10,000 Members and almost of our Members are ≥ 50 years older and suffering multiple comorbidities, mostly related to chronic cardiometabolic disease, as well as, diabetes, hypertension, stroke, arteriosclerosis, arthritis. Before 2015 none of plan´s member received 13-Valent Pneumococcal Conjugate Vaccine (PCV13). OBJECTIVES: To estimate number of inpatient and outpatient cases included the different of cost, before and after vaccination campaign in our high-risk older population from a private perspective (AXA Assistance). METHODS: We compared 2 periods: January-July 2015 and January–July 2016. A vaccination campaign was developed during November 2015 and was performed in 1000 high-risk members. RESULTS:  Period of January-July, 2015 were reported 379 cases of community-acquired pneumonia (CAP) (165 inpatient hospital, 214 outpatient hospital). In a period January-July 2016, 344 cases of CAP were reported (149 inpatient hospital, 195 outpatient hospitals). The average cost of inpatient and outpatient set was $ 10,879 and $ 265.56 respectively. Average time of hospitalization 2015 vs 2016 was 16.2 days UCI and 7.8 ward days vs 15.4 days UCI and 7.5 days. The average age hospitalized is 81 years and outpatient 74 years.  CONCLUSIONS: : PCV13 vaccine campaign reduces number of cases, length of stay. This intervention generate saving costs for PCABP administered by AXA Assistance